Stay in touch with NCATS by connecting via social media, joining our listserv for frequent announcements, and subscribing to our monthly e-newsletter.
Explore the full spectrum of translational science, including NCATS' role in transforming knowledge into treatments.
Review a list of all the innovative programs and initiatives that NCATS supports.
Read about NCATS' work to repurpose a drug to treat Duchenne muscular dystrophy, fund studies on tissue chips in space, support a CTSA Program-Eli Lilly training initiative, and more.
NCATS issued five grants to further refine tissue- and organ-on-chip platforms during experiments in-flight to the International Space Station U.S. National Laboratory.
Efforts are underway to study newborn screening for fragile X syndrome and other genetic diseases.
NCATS researchers and collaborators demonstrated that an unsuccessful cancer drug may have new life as a potential treatment for Duchenne Muscular Dystrophy.
Join NCATS on June 30 for its inaugural NCATS Day — Partnering with Patients for Smarter Science. Learn more.
Community Mentorship Helps Advance Multiple Sclerosis Research in Latinos
CTSA Program-supported investigators tackling inefficiencies in clinical trials
Christopher P. Austin, M.D.
Interested in creating biologically, physiologically and pharmacologically relevant assays for early-stage drug discovery? Check out our best-practices Assay Guidance Manual.
Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.
More News & Events …